Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: Clinical and therapeutic implications

Annals of the Rheumatic Diseases

Volumn 76, Issue 5, 2017, Pages

  Ombrello, Michael J ^a   Arthur, Victoria L ^a   Remmers, Elaine F ^b   Hinks, Anne ^c   Tachmazidou, Ioanna ^d   Grom, Alexei A ^e,f   Foell, Dirk ^g   Martini, Alberto ^h,i   Gattorno, Marco ⁱ   Özen, Seza ^j   Prahalad, Sampath ^k,l   Zeft, Andrew S ^m   Bohnsack, John F ⁿ   Ilowite, Norman T ^o   Mellins, Elizabeth D ^p   Russo, Ricardo ^q   Len, Claudio ^r   Hilario, Maria Odete E ^r   Oliveira, Sheila ^s   Yeung, Rae S M ^t,u   Rosenberg, Alan M ^v   Wedderburn, Lucy R ^w,x   Anton, Jordi ^y   Haas, Johannes Peter ^z   Rosen Wolff, Angela ^aa   Minden, Kirsten ^ab,ac   Tenbrock, Klaus ^ad   Demirkaya, Erkan ^j   Cobb, Joanna ^c   Baskin, Elizabeth ^a   Signa, Sara ^h   Shuldiner, Emily ^a   Duerr, Richard H ^ae,af   Achkar, Jean Paul ^m   Kamboh, M Ilyas ^af   Kaufman, Kenneth M ^e,f   Kottyan, Leah C ^e,f   Pinto, Dalila ^ag   Scherer, Stephen W ^ah   Alarcón Riquelme, Marta E ^ai,aj   Docampo, Elisa ^ak,al   Estivill, Xavier ^al,am   Gül, Ahmet ^an   Langefeld, Carl D ^ao   Thompson, Susan ^e,f   Zeggini, Eleftheria ^d   Kastner, Daniel L ^b   Woo, Patricia ^x   Thomson, Wendy ^c   more..

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^g UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^h UNIVERSITY OF GENOA   (Italy)

ⁱ G GASLINI INSTITUTE   (Italy)

^j HACETTEPE UNIVERSITY   (Turkey)

^k EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^m LERNER RESEARCH INSTITUTE   (United States)

ⁿ UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^o CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

^p STANFORD UNIVERSITY   (United States)

^q HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^r FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^s FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^t UNIVERSITY OF TORONTO   (Canada)

^u UNIVERSITY OF TORONTO   (Canada)

^v UNIVERSITY OF SASKATCHEWAN   (Canada)

^w UNIVERSITY COLLEGE LONDON   (United Kingdom)

^x UNIVERSITY COLLEGE LONDON   (United Kingdom)

^y UNIVERSITY OF BARCELONA   (Spain)

^z German Centre for Rheumatology in Children and Adolescents   (Germany)

^aa UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^ab CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^ac German Rheumatism Research Centre   (Germany)

^ad RWTH AACHEN UNIVERSITY   (Germany)

^ae UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^af UNIVERSITY OF PITTSBURGH   (United States)

^ag MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^ah HOSPITAL FOR SICK CHILDREN   (Canada)

^ai UNIVERSITY OF GRANADA   (Spain)

^aj KAROLINSKA INSTITUTE   (Sweden)

^ak UNIVERSITY OF LIÈGE   (Belgium)

^al UNIVERSITAT POMPEU FABRA   (Spain)

^am SIDRA MEDICAL AND RESEARCH CENTER   (Qatar)

^an ISTANBUL UNIVERSITY   (Turkey)

^ao WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

more..

Author keywords

Adult Onset Still's Disease; Gene Polymorphism; Juvenile Idiopathic Arthritis

Indexed keywords

ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; GENE LOCUS; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC RISK; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HISTOCOMPATIBILITY GENE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS; TREATMENT RESPONSE; ARTHRITIS, JUVENILE; CASE CONTROL STUDY; CHROMOSOME 1; GENETICS; MAJOR HISTOCOMPATIBILITY COMPLEX;

ARTHRITIS, JUVENILE; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 1; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 85005990049     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2016-210324     Document Type: Article

References (29)

1. Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet 2011;377:2138-49.
2. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2.
3. Bannatyne GA, Wohlmann AS. Rheumatoid arthritis: It's clinical history, etiology, and pathology. Lancet 1896;147:1120-5.
4. Still GF. On a form of chronic joint disease in children. Med Chir Trans 1897;80:47-60.
5. Mellins ED, Macaubas C, Grom AA. Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nat Rev Rheumatol 2011;7:416-26.
6. Davies R, Southwood T, Kearsley-Fleet L, et al. Standardized mortality rates are increased in patients with severe juvenile idiopathic arthritis. Rheumatology 2015;54:153.
7. Martini A. It is time to rethink juvenile idiopathic arthritis classification and nomenclature. Ann Rheum Dis 2012;71:1437-9.
8. Hugle B, Hinze C, Lainka E, et al. Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course. Pediatr Rheumatol Online J 2014;12:28.
9. Janow G, Schanberg LE, Setoguchi S, et al. The systemic juvenile idiopathic arthritis cohort of the childhood arthritis and rheumatology research alliance registry: 2010-2013. J Rheumatol 2016;43:1755-62.
10. Beukelman T. Treatment advances in systemic juvenile idiopathic arthritis. F1000Prime Rep 2014;6:21.
11. Solovieff N, Cotsapas C, Lee PH, et al. Pleiotropy in complex traits: challenges and strategies. Nat Rev Genet 2013;14:483-95.
12. Hinks A, Cobb J, Marion MC, et al. Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nat Genet 2013;45:664-9.
13. Thompson SD, Marion MC, Sudman M, et al. Genome-wide association analysis of juvenile idiopathic arthritis identifies a new susceptibility locus at chromosomal region 3q13. Arthritis Rheum 2012;64:2781-91.
14. Ombrello MJ, Remmers EF, Tachmazidou I, et al. HLA-DRB1∗11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis. Proc Natl Acad Sci USA 2015;112:15970-5.
15. Marchini J, Howie B, Myers S, et al. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 2007;39:906-13.
16. Howie B, Marchini J, Stephens M. Genotype imputation with thousands of genomes. G3 (Bethesda) 2011;1:457-70.
17. Magi R, Morris AP. GWAMA: software for genome-wide association meta-analysis. BMC Bioinformatics 2010;11:288.
18. Karlson EW, Chibnik LB, Kraft P, et al. Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk. Ann Rheum Dis 2010;69:1077-85.
19. Prahalad S, Conneely KN, Jiang Y, et al. Susceptibility to childhood-onset rheumatoid arthritis: investigation of a weighted genetic risk score that integrates cumulative effects of variants at five genetic loci. Arthritis Rheum 2013;65:1663-7.
20. Liley J, Wallace C. A pleiotropy-informed Bayesian false discovery rate adapted to a shared control design finds new disease associations from GWAS summary statistics. PLoS Genet 2015;11:e1004926.
21. DeWitt EM, Kimura Y, Beukelman T, et al. Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2012;64:1001-10.
22. Ungar WJ, Costa V, Burnett HF, et al. The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis: a systematic review. Semin Arthritis Rheum 2013;42:597-618.
23. Ruperto N, Lovell DJ, Quartier P, et al. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. Lancet 2008;372:383-91.
24. Record JL, Beukelman T, Cron RQ. Combination therapy of abatacept and anakinra in children with refractory systemic juvenile idiopathic arthritis: a retrospective case series. J Rheumatol 2011;38:180-1.
25. Birnbaum RY, Clowney EJ, Agamy O, et al. Coding exons function as tissue-specific enhancers of nearby genes. Genome Res 2012;22:1059-68.
26. Li X, Zhang Q, Ding Y, et al. Methyltransferase Dnmt3a upregulates HDAC9 to deacetylate the kinase TBK1 for activation of antiviral innate immunity. Nat Immunol 2016;17:806-15.
27. Li B, Samanta A, Song X, et al. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc Natl Acad Sci USA 2007;104:4571-6.
28. Clark RI, Tan SW, Pean CB, et al. MEF2 is an in vivo immune-metabolic switch. Cell 2013;155:435-47.
29. Vojinovic J, Damjanov N, D'Urzo C, et al. Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2011;63:1452-8.